• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® ESOPHAGEAL CONTROLLED-RELEASE STENT - FULLY COVERED; ESW PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® ESOPHAGEAL CONTROLLED-RELEASE STENT - FULLY COVERED; ESW PROSTHESIS, ESOPHAGEAL Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Information (3190)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Investigation is still pending, a follow up mdr will be submitted to include investigation conclusions.
 
Event Description
This file is being created to cover a complaint reference in the study: ¿fully-covered esophageal stent migration rates in benign and malignant disease: a multicenter retrospective study¿.The rate of clinically relevant migration as defined by stent migration followed by reintervention via endoscopy for stent replacement is unknown.The goal of this study is to gain insight into the total migration rate and clinically relevant migration rate of different types of fcsems placed within benign and malignant strictures with specific attention paid to stent manufacturer, diameter, and length.Multicenter retrospective analysis of endoscopic data from patients with fcsems placed within benign or malignant strictures.A total of 369 patients were included, 161 of whom had benign strictures and 208 of whom had malignant strictures.Replacement of a stent is indicated based on the degree of migration as well as clinical symptoms (i.E.Recurrence of dysphagia, pain, etc) and thereby an inability for the stent to perform its intended function, which we define as clinically relevant migration.The evolution stent (cook medical) which accounted for 55 (15%) of the stents placed.This file is being opened to address: "a total of 208 fscems were placed for malignant strictures (35 of the 208 devices were cook evolution devices).Of the 208 fully-covered self-expanding metal stents (fcsems), a total of 30 (14 %) were noted to have a late complication that required stent replacement.Two stent¿s which were placed for malignant strictures were replaced due to other non-defined complications.As the study does not detail which manufacturer's stents resulted in the other non-defined complications, this complaint has been logged as there is a possibility the stent's were cook evolution device's.
 
Manufacturer Narrative
Cook ireland ltd (manufacturer) is submitting this report on behalf of cook medical incorporated (cmi)(importer).Exemption number: e2016031.Information pertaining to section g.1 as follows: importer site contact and address: (b)(4).Importer site establishment registration number: (b)(4).The evo- fully-covered esophageal stent device of unknown lot number was not returned to cook ireland for evaluation.With the information provided, document based investigation was conducted.This file was created from the attached journal article to address the other non-defined complications in malignant stricture it may be noted that the device in question has not been confirmed to be evolution device.Documents review including ifu review: as the evo fully-covered esophageal stent - unknown devices from unknown lot numbers, a review of the relevant manufacturing records cannot be conducted.Prior to distribution all evo- (fully-covered esophageal stent) devices are subject to visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.As per the instructions for use, ifu0061-5, which informs the user about the potential complications "additional complications include, but are not limited to : stent misplacement and/or migration," on review of the information provided, there is no evidence to suggest that the user did not follow the instructions for use.A definitive root cause for the customer complaint could not be determined as the device was not returned.Based on limited information available, this complaint has been deemed to be negative feedback.Customer complaint is confirmed based on customer testimony.The patient outcome is unknown.Complaints of this nature will continue to be monitored for potential emerging trends.[fully covered stent migration in benign and malignant_adler 2019.Pdf].
 
Event Description
This file is being created to cover a complaint reference in the study: ¿fully-covered esophageal stent migration rates in benign and malignant disease: a multicenter retrospective study¿ the rate of clinically relevant migration as defined by stent migration followed by reintervention via endoscopy for stent replacement is unknown.The goal of this study is to gain insight into the total migration rate and clinically relevant migration rate of different types of fcsems placed within benign and malignant strictures with specific attention paid to stent manufacturer, diameter, and length.Multicenter retrospective analysis of endoscopic data from patients with fcsems placed within benign or malignant strictures.A total of 369 patients were included, 161 of whom had benign strictures and 208 of whom had malignant strictures.Replacement of a stent is indicated based on the degree of migration as well as clinical symptoms (i.E.Recurrence of dysphagia, pain, etc) and thereby an inability for the stent to perform its intended function, which we define as clinically relevant migration.The evolution stent (cook medical) which accounted for 55 (15%) of the stents placed.This file is being opened to address: "a total of 208 fscems were placed for malignant strictures (35 of the 208 devices were cook evolution devices).Of the 208 fully-covered self-expanding metal stents (fcsems), a total of 30 (14 %) were noted to have a late complication that required stent replacement.Two stent¿s which were placed for malignant strictures were replaced due to other non-defined complications.As the study does not detail which manufacturer's stents resulted in the other non-defined complications, this complaint has been logged as there is a possibility the stent's were cook evolution device's.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® ESOPHAGEAL CONTROLLED-RELEASE STENT - FULLY COVERED
Type of Device
ESW PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
MDR Report Key8715701
MDR Text Key148528302
Report Number3001845648-2019-00277
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
PMA/PMN Number
K093619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/19/2019
Event Location Hospital
Initial Date Manufacturer Received 06/19/2019
Initial Date FDA Received06/20/2019
Supplement Dates Manufacturer Received06/19/2019
Supplement Dates FDA Received07/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-